Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

The Animal Antibacterial and Antibiotics Market is being driven by several key factors. Rising livestock production and ...

Boehringer Ingelheim & WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention: Ingelheim, Germany Wednesday, October 16, ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts ...

With a population exceeding 1 million, Gwinnett offers a thriving community that blends urban development with a small-town ...

Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...

While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...

The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...

Earlier this month, Boehringer Ingelheim, a leader in animal health, said it is stepping up its efforts to combat rabies in the country. It said that in response to the worst outbreak of rabies in ...